CBIH

$0.00+100.00%visit website

Cannabis Bioscience International Holdings, Inc.

Market Cap

$2M

Live price × SEC shares (Apr 16, 2026)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

1.08

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Feb 2026 · negative earnings

No 10-Q/10-K since Apr 16, 2026

P/S (TTM)

18.8

TTM to Feb 2026 · revenue

No 10-Q/10-K since Apr 16, 2026

P/B

N/M

TTM to Feb 2026 · negative equity

No 10-Q/10-K since Apr 16, 2026

EV/EBITDA (TTM)

—

EV / TTM EBITDA

No 10-Q/10-K since Apr 16, 2026

Loading…

Financial Statements

USD thousands	Q4 FY2025 May 31, 2025	Q1 FY2026 Aug 31, 2025	Q2 FY2026 Nov 30, 2025	Q3 FY2026 Feb 28, 2026	TTM Feb 28, 2026
Revenue	35	24	53	11	124
Cost of revenue	4.5	8.1	10.5	3.0	26.2
Gross profit	30.4	16.1	42.8	8.2	97.4
Total operating expenses	165	91	139	101	496
Operating income	(135)	(75)	(96)	(93)	(399)
Interest expense	103	17	18	11	149
Net income	(212)	(83)	(117)	(104)	(515)
EPS (basic) ($)		0.00	0.00	0.00	0.00
EPS (diluted) ($)		0.00	0.00	0.00	0.00
Weighted avg. shares (basic)		11,626,749	11,626,749	11,626,749
Weighted avg. shares (diluted)		11,626,749	11,626,749	11,626,749

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Apr 16, 2026, period ended Feb 28, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 16 more quarters, back to Aug 2010, with Tormere Pro.

Corporate Events (8-K)

0 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Jan 22, 2025 accepted 8:47 PM ET	1.01Material agreement	Document SEC ↗
Nov 26, 2024 accepted 10:26 PM ET	5.02Officer / director change8.01Other events	Document SEC ↗